Ogden Christopher
CIK 0001914523
SVP, Finance and Accounting
Filings
14
Latest Mar 19, 2026
Issuers covered
1
Showing
14 of 14
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 75% | +4.3% | +8.0% | +20.6% | -21.6% |
| 90 days | 7 | 71% | -34.3% | +19.1% | +37.2% | -307.3% |
| 180 days | 7 | 43% | -33.3% | -2.2% | +44.5% | -229.5% |
| 365 days | 5 | 40% | -121.4% | -6.7% | +69.3% | -628.5% |
Issuers
Companies where Ogden Christopher has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CTMX | Cytomx Therapeutics, Inc. | 14 | Mar 19, 2026 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|